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see Watts et al., 2005; Whitman and Greer, 2009). This dogma was 
deeply entrenched in the Neuroscience community, and Altman’s 
(1962) discovery of newborn cells in well-defined areas of the adult 
rodent brain was largely ignored. The phenomenon was reexam-
ined in the 1970–1980s, when Michael Kaplan (Kaplan and Hinds, 
1977) and Fernando Nottebohm (Goldman and Nottebohm, 1983) 
demonstrated the presence of newborn cells in the adult brain of 
mice and canaries, respectively, and showed that these cells had 
ultrastructural characteristics of neurons. However, such findings 
could not be repeated in adult rhesus monkeys, where proliferat-
ing cells appeared to be glial and endothelial cells and not neu-
rons (Rakic, 1985; Eckenhoff and Rakic, 1988). Thus, neurogenesis 
seemed to be absent in adult primates (Eckenhoff and Rakic, 1988).
The field of adult neurogenesis finally took off in the 1990s 
with  the  development  of  new  technologies.  First,  the  use  of 
3H-thymidine, a radioactive nucleotide used to study prolifera-
tion when incorporated into the cells during the S phase of the cell 
cycle, was replaced by its analog, bromodeoxyuridine (BrdU), which 
could be detected by a specific antibody. Utilization of the BrdU 
for labeling of newborn cells via immunohistochemistry allowed 
their further studies by co-labeling with specific neuronal mark-
ers (Miller and Nowakowski, 1988). Further, it was shown that 
neuroprogenitor cells (NPCs), isolated from adult mouse brains, 
proliferated and differentiated into neurons and astrocytes in vitro 
(Reynolds and Weiss, 1992). In addition, NPCs labeled with viral 
vectors were able to migrate and differentiate into neurons in the 
adult mouse brain (Lois and Alvarez-Buylla, 1993), demonstrating 
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mammalIan neurogenesIs dIscovery
The  discovery  of  adult  neurogenesis  crushed  the  century-old 
dogma that no new neurons are formed in the mammalian brain 
after birth. However, this finding and its acceptance by the scien-
tific community did not happen without hurdles. At the begin-
ning of the last century, based on detailed observations of the 
brain anatomy reported by Santiago Ramon y Cajal and others, it 
was established that the human nervous system develops in utero 
(Colucci-D’Amato et al., 2006). In adult brains, it was thought, no 
more neurons could be generated, as the brain is grossly incapable 
of regenerating after damage (for a more detailed historical report 
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existence of adult neurogenesis in humans was firmly established 
when, in 1998, Gage and colleagues demonstrated for the first 
time that new neurons were produced in the adult hippocampus 
(Eriksson et al., 1998).
Currently,  adult  neurogenesis  is  one  of  the  hot  topics  in 
Neuroscience especially because of the new opportunities it may bring 
for treatments of neurodegenerative diseases, either by harnessing 
resident progenitors to regenerate the lost tissue (Sohur et al., 2006) 
or by cell transplantation therapies (Goldman and Windrem, 2006). 
The field is currently on the rise, as shown by the exponential growth 
of publications with the key words “adult” AND “neurogenesis OR 
neural stem cells” (PubMed search up to December 31, 2010): a total 
of 6,437 papers have been published, of which 57% (3,695 papers) 
was published in the last 5 years (Figure 1). However, only 8% of 
published papers (530 papers) deal with human data (search including 
the term “human” in the title), suggesting that the research on adult 
neurogenesis in humans is still in its infancy. Thus, the actual knowl-
edge on adult human neurogenesis is limited and in many cases, data 
is directly extrapolated from the rodent literature. Herein, we review 
the methodologies used to assess adult human neurogenesis and its 
status in several neuropsychiatric disorders.
methods to assess neurogenesIs In humans
The extent of our knowledge on adult human neurogenesis directly 
correlates with the type of available techniques that can be applied 
to human brain tissue research. Several methodologies exist, but 
each method yields different sensitivity, specificity, and ultimately 
different  units  of  quantification,  thus  rendering  it  difficult  to 
compare different studies. In addition, some methodologies can 
assess only proliferation (NPCs or total proliferating cells) while 
others can provide the data on neurogenesis [neuroblasts (NBs, 
neuronal committed cells) or newborn neurons]. Herein, we review 
the advantages and disadvantages of methods used to assess adult 
human neurogenesis both ex vivo and in vivo.
methods to assess neurogenesIs on postmortem and 
bIopsIed tIssue
The majority of the methodologies used to study neurogenesis ex 
vivo have been inherited from the rodent literature, where they have 
been thoroughly validated (Figure 2). These techniques require 
brain tissue that is obtained postmortem, either frozen fresh imme-
diately after death or, more frequently, fixed and stored in brain 
tissue banks. In both cases, it is important to note that the cause 
of death, presence of brain and/or systemic illnesses, age of death, 
and postmortem interval (the time from death to tissue fixation) 
may be confounding factors when interpreting the results (Boldrini 
et al., 2009). Alternatively, brain tissue can also be obtained from 
biopsies or surgical resections, such as in temporal lobectomy due 
to intractable epilepsy.
Bromodeoxyuridine labeling
Bromodeoxyuridine is widely used in animal models to quantify the 
number of dividing cells in a tissue and to trace their progeny. When 
administered systemically, it is incorporated into the DNA during 
the S phase of the cell cycle and is transmitted to the daughter 
cells, as long as it is not diluted through many rounds of prolifera-
tion (Karpowicz et al., 2005). Using a variety of specific anti-BrdU 
antibodies, it can be detected by immunohistochemistry. Although 
it can be mutagenic (Rakic, 2002a), BrdU was approved in 1995 by 
the Food and Drug Administration (FDA) to be used in humans 
under the commercial name of Broxine/Neomark as a radiation 
sensitizer in the treatment of primary brain tumors1. Furthermore, 
BrdU is currently used in several clinical trials to measure cell cycle 
kinetics in patients with hematologic malignancies, to study white 
blood cell replication and survival in patients with human immu-
nodeficiency virus, and to assess the degree of tumor proliferation 
in biopsies as well as to treat patients with pancreatic tumors as an 
antineoplastic agent2. It was the treatment with BrdU of patients 
who suffered from larynx, pharynx, or tongue cancers that enabled 
the detection of proliferating NPCs in the hippocampus (Eriksson 
et al., 1998), the discovery which paved the way for further investi-
gations of adult neurogenesis in the human brain.
The major advantage of BrdU labeling is its sensitivity to 
detect proliferating cells compared to other immunohistological 
methods. For instance, neurogenesis in adult rhesus monkeys 
was only detected using BrdU (Kornack and Rakic, 1999) but not 
FigUre 1 | Published papers on adult neurogenesis per quinquennium. The graph shows the accumulated papers published from 1960 onward, searched in 
PubMed with the search terms “adult” AND (“neurogenesis” OR “stem cells”). The asterisks show the total number of papers, and the filled squares show those 
papers with the term “human” in their title.
1http://www.fda.gov/ohrms/dockets/dailys/00/mar00/030100/lst0094.pdf\
2http://clinicaltrials.gov/ct2/result?intr=bromodeoxyuridine
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Sierra et al.  Methods to assess adult neurogenesis in humansFigUre 2 | Methods to assess adult human neurogenesis in resected or 
postmortem brain samples. Brain samples from live individuals can be obtained 
by surgical resection of the focus of the seizures in intractable epilepsy or brain 
tumors. Alternatively, bank tissues store frozen or fixed brain samples from 
accidental deaths and aging individuals, some of which may have been treated with 
BrdU. Once the tissue is obtained, three main methods can be applied to study 
neurogenesis: (A) Immunodetection of BrdU and/or proliferation and cell-type 
specific biomarkers in fixed tissue, followed by analysis by confocal analysis. An 
example of new born neurons in the SGZ of the hippocampus of an aging patient is 
shown in (A1) NeuN+ neurons (red), (A2) BrdU labeling (green), (A3) GFAP+ 
astrocytes (blue), (A4) merged image showing one newborn neuron labeled with 
BrdU and NeuN, but not with GFAP (arrow); and non-specific fluorescence emission 
due to lipofuscin accumulation in old tissue (arrowhead). Scale bar is 25 μm. 
(B) Culture of NPCs. In this case, the fresh tissue is dissociated and transfected with 
a reporter gene (GFP) driven by a Tα1 tubulin promoter, an early neuronal regulatory 
gene. The transfected cells are then purified by FACS and cultured in vitro. The 
grown cells differentiate into fully functional neurons which when patch-clamped in a 
voltage-clamped configuration (B1) show typical depolarizations of the voltage-
gated sodium currents measured in nanoAmperes (nA) over a time course of 
milliseconds (ms) (B2). (C) Determination of the 14C content. Cell nuclei from 
prefrontal cortex samples are purified by density gradients, labeled with NeuN and 
purified by FACS. Next, their DNA is purified and the 14C content is analyzed by mass 
spectrometry. (C1) FACS plot showing the expression of NeuN (vertical axis) versus 
the area of the forward scatter (FSC-A, which is considered a measure of the particle 
size). The neuronal nuclei (NeuN+, orange) are separated from the rest of the nuclei 
(NeuN−, green). (C2) 14C content of the sorted nuclei (∆14C, given in relation to a 
universal standard and corrected for radioactive decay) compared to the atmosphere 
14C content (blue line) and the age of the individual (vertical black line). Neuronal 
nuclei (orange triangles) have a 14C content that indicates that their age is coincident 
with that of the individual. Non-neuronal nuclei (green circles) are younger than the 
individual, making the non-sorted (black squares) cells younger than the individual in 
average as well. Figures (A1–A4) and (B1–B2) are reprinted by permission from 
Macmillan Publishers Ltd: Nature Medicine, Eriksson et al. (1998), copyright 1998; 
and Roy et al. (2000), copyright 2000, respectively. Figures (C1–C2) are reprinted 
by permission from Bhardwaj et al. (2006), copyright 2006, National Academy of 
Sciences, U.S.A.
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increasing the number of samples that can be studied. However, 
these markers only label proliferating cells and cannot be used to 
trace their fate or to assess actual neurogenesis. Importantly, pro-
liferation biomarkers in neurogenic regions are usually assumed 
to label NPCs, but it is also possible that they label proliferating 
astrocytes, oligoprogenitors, or endothelial cells. Gliogenesis should 
be ruled out by double-labeling with specific glial biomarkers.
Cell-specific biomarkers can also be detected using specific anti-
bodies (thoroughly reviewed by von Bohlen Und Halbach, 2007; 
Encinas and Enikolopov, 2008). The most common cell biomark-
ers used for studies of the human tissue are described in Table 1: 
Nestin (Lendahl et al., 1990), GFAP (Doetsch et al., 1997), Vimentin 
(Doetsch  et  al.,  1997),  EGFR  (Danilov  et  al.,  2009),  Musashi 
(Sakakibara and Okano, 1997), PSA-NCAM (Doetsch et al., 1997), 
Doublecortin (DCX; des Portes et al., 1998), NeuroD (Miyata et al., 
1999), TOAD-64 (Minturn et al., 1995), NeuN (Mullen et al., 1992; 
Kim et al., 2009), NSE (Kaiser et al., 1989), and βIII-Tubulin (Encinas 
and Enikolopov, 2008). However, caution must be observed when 
using  these  antibodies  to  assign  the  cell  identity.  For  instance, 
apart from labeling migrating NBs, PSA-NCAM is also involved in 
synaptic plasticity (Dityatev et al., 2004) and is expressed in non-
neurogenic areas in rodents (Nacher et al., 2002). In addition, the 
specificity of DCX as a marker for neurogenesis has been recently 
challenged, as it has been found in mature astrocytes in the human 
neocortex in patients suffering from neurodegeneration (Verwer 
et al., 2007). Finally, some authors (Boekhoorn et al., 2006), but 
not others (Liu et al., 2008), find that DCX immunolabeling is very 
sensitive to postmortem delay, an important confounding factor 
when comparing human postmortem samples.
NPC culture
Human NPCs have been isolated and cultured in vitro. Originally, 
Steindler and colleagues were able to grow NPCs from the tem-
poral lobe tissue extracted from patients with intractable epilepsy. 
These NPCs proliferated in vitro in the form of neurospheres and 
differentiated into neurons and astrocytes (Johansson et al., 1999; 
Kukekov et al., 1999). Later on, Goldman and colleagues refined the 
technique and were able to specifically isolate the NPCs (Roy et al., 
2000). They transfected cells from mixed brain cultures with viral 
constructs expressing a humanized green fluorescent protein (GFP) 
under regulatory elements of the nestin or the early neuronal Tα1 
tubulin genes, and then purified the NPCs based on the expression 
of the transgene by fluorescence-activated cell sorting (FACS). The 
isolated NPCs divided in culture and gave rise to physiologically 
active neurons (Roy et al., 2000). This technique was not designed 
for quantification purposes and, thus, cannot be used to assess 
the degree of neurogenesis in different disorders or after differ-
ent treatments. Nonetheless, it has generated a great excitement 
because it was seen as the first serious step toward cell replacement 
therapies for human neurological diseases by transplantation of 
either precursors or already differentiated cells (Antel et al., 2000).
14C retrospective labeling
Similar to the 14C-dating used in archeology, this method uses the 
14C-content to assess the average age of the cells present in a par-
ticular tissue (Spalding et al., 2005; Bhardwaj et al., 2006). Due to 
H3-thymidine, which also incorporates into the DNA of divid-
ing cells (Rakic and Nowakowski, 1981). In addition, prolifera-
tion in the adult human hippocampus was found using BrdU 
(Eriksson et al., 1998), but not other markers of proliferation 
such as MiB-1 (Seress et al., 2001). Another advantage of BrdU 
labeling is utilization of pulse-and-chase analysis, which enables 
studies of both proliferation (hours after the BrdU injection) 
and differentiation (days or months after the BrdU injection). 
Such studies may ultimately be used to distinguish between neu-
rogenesis and gliogenesis, a particularly significant feature in 
human brain diseases.
Despite its wide use, BrdU labeling has some drawbacks. For 
instance, BrdU does not diffuse freely through the blood–brain 
barrier (BBB), but rather, it likely uses the deoxythymidine trans-
porters (Spector and Johanson, 2007). Therefore, conditions that 
disrupt the BBB, such as inflammation, irradiation, status epilep-
ticus, trauma, etc., may lead to different BrdU availability which, 
in turn, leads to labeling of different number of cells without 
actual changes in proliferation (von Bohlen Und Halbach, 2007). 
To overcome this possible cause of misinterpretation of the data, 
it is particularly important to determine the integrity of the BBB 
when comparing neurogenesis in healthy and diseased individuals. 
Furthermore, BrdU can label phenomena other than proliferation, 
such as DNA turnover or repair, or abortive reentry in the cell 
cycle during apoptosis (Rakic, 2002a,b). Finally, some dividing cells 
may preferentially use de novo synthesis of deoxythymidine rather 
than the salvage enzymes which phosphorylate existing deoxynu-
cleotides (including BrdU) to generate the deoxynucleotides for 
DNA synthesis during the S phase (Spector and Johanson, 2007). 
In such cases, BrdU labeling will not correlate with the proliferative 
activity of the cells. Thus, while it has revolutionized the studies of 
neurogenesis, BrdU labeling should be meticulously analyzed to 
avoid possible misinterpretations as noted above.
Expression of cell-specific biomarkers
Particular cell types and particular stages of the cell cycle of dividing 
cells can be assessed by specific antibodies. When utilizing these 
reagents for immunostaining of the human tissue, it is impor-
tant to take into account antigenicity, which can be affected by the 
delayed fixation of the postmortem tissue (Boekhoorn et al., 2006; 
Liu et al., 2008) and the specificity of the antibodies, which may 
be related to a particular species (for example, antibodies which 
work for rodent tissue may not work for human tissue). Ideally, 
quantification of cells expressing the biomarker of interest should 
be obtained using unbiased stereology, such as the optical dissector 
method (Lemmens et al., 2010), although in human samples this 
goal can be difficult to achieve due to the low number of proliferat-
ing cells (Liu et al., 2008).
Proliferation biomarkers are expressed while cells are cycling 
(Table 1), such as Ki-67 (Hall and Woods, 1990; Yerushalmi et al., 
2010) and MCM2 (Stoeber et al., 2001; Bailis and Forsburg, 2004). 
Ki-67 immunolabeling relies heavily on pH (Boekhoorn et al., 
2006); thus other antibodies against the Ki67 antigen, such as MIB-
1, have been developed for different tissue conditions (Cattoretti 
et al., 1992). Another widely used marker is PCNA (Takasaki et al., 
1981), although it is also expressed by some non-proliferating 
cells (Rakic, 2002a). Compared to BrdU, these markers offer the 
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Antigen  Function  expression  references
ProliFerATioN BioMArKers
Ki67 Unknown Expression 
during G1-M
Del Bigio (1999), Blumcke et al. (2001), Bedard and 
Parent, (2004), Sanai et al. (2004), Boekhoorn et al. 
(2006), Jin et al. (2006), Macas et al. (2006), Reif et al. 
(2006), Ziabreva et al. (2006), Fahrner et al. (2007), Shen 
et al. (2008), Boldrini et al. (2009), Mattiesen et al. (2009), 
Knoth et al. (2010), Marti-Fabregas et al. (2010)
PCNA Proliferating cell nuclear antigen, 
a co-factor of DNA-Polδ
Synthesized 
during S phase
Bernier et al. (2000), Curtis et al. (2003, 2005a,b), Bedard 
and Parent (2004), Hoglinger et al. (2004), Crespel et al. 
(2005), Jin et al. (2006), Liu et al. (2008), Shen et al. 
(2008), Gerber et al. (2009), Kam et al. (2009), Mattiesen 
et al. (2009), Knoth et al. (2010)
MCM2  Minichromosome maintenance 
protein 2, a DNA helicase
Throughout 
cell cycle
 Jin et al. (2006), Liu et al. (2008), Shen et al. (2008), 
Knoth et al. (2010)
Cell-sPeCiFiC BioMArKers
Nestin An intermediate filament NPC, 
astrocytes, 
radial glia, 
perivascular 
cells
Arnold and Trojanowski (1996), Blumcke et al. (2001), 
Bedard and Parent (2004), Hoglinger et al. (2004), 
Crespel et al. (2005), Jin et al. (2006), Macas et al. 
(2006), Ziabreva et al. (2006), Boldrini et al. (2009), 
Mattiesen et al. (2009), Knoth et al. (2010), Marti-
Fabregas et al. (2010)
EGFR Epidermal growth factor receptor C cells, A cells Weickert et al. (2000), Hoglinger et al. (2004)
GFAP Glial fibrillary acidic protein, 
an intermediate filament
Quiescent 
NPCs, B cells, 
radial glia, 
astrocytes
Eriksson et al. (1998), Del Bigio (1999), Bernier et al. 
(2000), Weickert et al. (2000), Blumcke et al. (2001), 
Curtis et al. (2003), Hoglinger et al. (2004), Sanai et al. 
(2004), Crespel et al. (2005), Boekhoorn et al. (2006), 
Macas et al. (2006), Fahrner et al. (2007), Shen et al. 
(2008), Boldrini et al. (2009), Gerber et al. (2009), Kam 
et al. (2009), Mattiesen et al. (2009), Knoth et al. (2010), 
Marti-Fabregas et al. (2010)
Vimentin An intermediate filament Quiescent 
NPCs, B cells, 
astrocytes
Arnold and Trojanowski (1996), Curtis et al. (2003, 
2005a), Crespel et al. (2005), Fahrner et al. (2007), 
Mattiesen et al. (2009)
Musashi An RNA-binding protein NPC, 
astrocytes
Crespel et al. (2005), Macas et al. (2006), Ziabreva et al. 
(2006), Shen et al. (2008), Mattiesen et al. (2009)
PSA-NCAM Polysialylated cell adhesion 
molecule, involved in cell 
migration
Migrating 
neuroblasts
Mikkonen et al. (1998), Bernier et al. (2000), Weickert 
et al. (2000), Bedard and Parent (2004), Hoglinger et al. 
(2004), Crespel et al. (2005), Curtis et al. (2005b), 
Boekhoorn et al. (2006), Macas et al. (2006), Liu et al. 
(2008), Kam et al. (2009), Marti-Fabregas et al. (2010)
DCX Doublecortin, promotes 
microtubule proliferation
Neuroblasts 
and neurons
Bedard and Parent (2004), Crespel et al. (2005), 
Boekhoorn et al. (2006), Jin et al. (2006), Fahrner et al. 
(2007), Liu et al. (2008), Shen et al. (2008), Gerber et al. 
(2009) 
NeuroD A transcription factor, involved in 
neuronal commitment
Neuroblasts 
and neurons
Bedard and Parent (2004), Knoth et al. (2010)
(Continued)
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rally relax back to their original conformation with time constants 
T1 (spin–lattice relaxation time, for longitudinal magnetization) 
and T2 (spin–spin relaxation time, for transversal magnetization; 
Maletic-Savatic et al., 2008). The difference in relaxation times 
of different molecules, such as water and fat, is used to generate 
detailed MRI images of the brain. In addition, further information 
can be extracted from these constants, and different MR modalities 
have been adapted to study neurogenesis (Modo and Bulte, 2011).
The major advantage of MR-based methods is that they are per-
formed in live individuals with no side effects, supporting repeated 
measures and longitudinal studies. Thus, these methods allow a more 
controlled experimental design, and variables such as the cause or age 
of death no longer have to be taken into account. Nonetheless, these 
methods rely on correlations to indirectly quantify neurogenesis, and 
extensive validation in both rodents and humans is required to dem-
onstrate that they are specific for neurogenesis. More importantly, it is 
essential to determine whether the data correlate with the number of 
NPCs, proliferating NPCs (versus other cell types that proliferate), or 
newborn neurons. Another major advantage of MRI-based methods 
is that MRI scanners are widely available in hospitals and research 
centers worldwide. Thus, these methods could be easily implemented 
in many labs and offer a unique research opportunity to increase our 
understanding of the role of adult neurogenesis in humans.
Cerebral blood volume measurements
Cerebral blood volume (CBV) can be measured by several methods, 
one of which is MRI. In MR-based CBV measurements, the contrast 
agent gadolinium is injected systemically. The chelated gadolinium 
used is a non-toxic highly lipophobic agent, thus restricted to the 
intravascular space when the BBB is not challenged (Zaharchuk, 
2007). Due to its paramagnetic properties, it creates variations in 
the local magnetic field which lead to decreased T1 signal inten-
sity. These changes can be used to generate maps of the CBV and 
cerebral blood flow (CBF) by an array of computational methods 
(reviewed in Zaharchuk, 2007). Among these, the steady-state T1 
the extensive testing of nuclear weapons in the 1950–1960s, large 
quantities of 14C were generated; since then, the 14C levels in the 
biosphere have decayed at a known rate. This 14C incorporates into 
the cells, matching the 14C levels in the atmosphere. The exception 
is genomic DNA because the molecular composition of DNA is 
stable after the last cell division (except in case of DNA repair). The 
DNA 14C-content reflects the age of the cell and not the atmospheric 
levels (Spalding et al., 2005; Bhardwaj et al., 2006). Thus, the strategy 
devised by the Jonas Frisen’s group was to isolate cell nuclei from 
fresh or frozen brain autopsy specimens and label them with NeuN. 
Next, neuronal nuclei (NeuN+) were sorted by FACS, their DNA 
purified and the 14C-content measured by accelerator mass spec-
trometry (Spalding et al., 2005; Bhardwaj et al., 2006). Using this 
technique, it was shown that neurogenesis in the adult neocortex 
is absent or very limited because the age of the neurons matched 
the age of the individual and had 14C levels similar to atmospheric 
levels at the time when the individual was born (Bhardwaj et al., 
2006). On the contrary, NeuN-nuclei, including glial cells which 
are known to have a higher turnover rate, showed an average age 
several years younger than the age of the individual, suggesting that 
those were cells born during adulthood (Bhardwaj et al., 2006). 
This method yields high sensitivity as it has been estimated that 
it detects newborn cells down to 1% of the population (Bhardwaj 
et al., 2006). However, it only provides the average age of the neu-
rons in the tissue and does not allow dating or tracing of individual 
cells. Surprisingly, this method has not yet been used to test adult 
neurogenesis in the hippocampus or the olfactory bulb (OB), the 
two major areas of adult neurogenesis.
methods to assess neurogenesIs iN vivo
More recently, methods have been specifically designed to detect 
neurogenesis in live human brain by means of magnetic resonance 
imaging (MRI; Figure 3). In the MRI scanner, the subjects are 
exposed to a harmless magnetic field that aligns the magnetic 
spin of all the protons in the tissue in a low energy configuration; 
next, the subjects receive radiofrequency electrical stimulation, 
Table 1 | Continued
Antigen  Function  expression  references
TOAD64 Turned on after division 64, a 
membrane associated protein from 
the TUC4 family involved in axonal 
growth
Neuroblasts Jin et al. (2006), Shen et al. (2008), Gerber et al. (2009), 
Mattiesen et al. (2009), Knoth et al. (2010)
NeuN A splicing factor of the Fox-3 family Neurons Eriksson et al. (1998), Weickert et al. (2000), Blumcke et al. 
(2001), Curtis et al. (2003), Crespel et al. (2005), Fahrner 
et al. (2007), Liu et al. (2008), Boldrini et al. (2009), Knoth 
et al. (2010), 
βIII-Tubulin A microtubule  Neurons Arnold and Trojanowski (1996), Bernier et al. (2000), 
Weickert et al. (2000), Blumcke et al. (2001), Curtis et al. 
(2003, 2005b), Bedard and Parent (2004), Hoglinger et al. 
(2004), Jin et al. (2006), Macas et al. (2006), Liu et al. 
(2008), Shen et al. (2008), Knoth et al. (2010)
NSE Neuron specific enolase Neurons Eriksson et al. (1998), Del Bigio (1999) 
The function and expression of the different markers and the papers in which they were used are shown.
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of the steady-state T1 method, compared to other methods such 
as bolus tracking (also called dynamic imaging), is that it renders 
absolute estimations of the CBV, supporting longitudinal studies 
of brain perfusion, and has high spatial resolution. This method 
has been validated through correlation with estimations of gray 
matter CBV using other imaging modalities. However, it requires 
method is based on the assumption that the MRI signal derives from 
two separate compartments – intravascular (vessels) and extravas-
cular (brain parenchyma; Lin et al., 1999). When gadolinium is 
administered, only the T1 signal from the intravascular compart-
ment will decrease, assuming the BBB is intact. Then, the difference 
between pre-contrast and post-contrast images normalized over a 
voxel that contains only blood, such as the sagittal sinus, is used 
FigUre 3 | live methods to assess adult human neurogenesis. These 
methods are based on magnetic resonance, using MRI scanners available in 
hospitals worldwide. Because there are no side effects, both healthy and 
diseased people can be re-scanned throughout aging, before and after 
exercise, to follow-up the effect of pharmacological interventions, etc. Two 
main methods have been developed to indirectly quantify adult human 
neurogenesis using different MR modalities: (A) CBV measurement. The 
dentate gyrus CBV is a proxy for neurogenesis in physical exercise 
paradigms. This method is based on the consecutive correlation of 
neurogenesis–angiogenesis, and angiogenesis–CBV. (A1) High resolution 
MRI slice of the adult human hippocampus (right panel), showing the 
different hippocampal subregions (entorhinal cortex, EC, green; dentate 
gyrus, DG, red; cornu ammonis 1, CA1, light blue; and subiculum, SUB, 
yellow; central panel) and a typical hippocampal CBV map (warmer colors 
indicate higher CBV). (A2) Quantification of the mean relative hippocampal 
CBV (rCBV), before (white bars) and after (black bars) exercise in healthy 
humans. As in mice, physical exercise resulted in a significant increase in 
CVB only in the DG (asterisk). (B) Spectroscopy. A lipidic metabolite 
resonating at 1.28 ppm was identified as a marker of rodent NPCs. (B1) 
Positioning of the voxel of interest in the cortex and the hippocampus of a 
healthy person. (B2) Spectroscopic analysis of the metabolite content in the 
hippocampal voxel using SVD and FFT (small upper insert). Identified 
metabolites are myoInositol (mI, light blue), choline (Cho, purple), creatine 
(green), N-acetylaspartate (NAA, dark blue), and the 1.28 ppm metabolite 
(red). (B3) Quantification of the abundance of the 1.28 ppm metabolite in the 
cortical (CTX) and hippocampal voxels (LH and RH for left and right 
hippocampus, respectively), normalized over the amplitude of the creatine 
peak. The hippocampi had much higher content of the 1.28 ppm metabolite 
than the cortex. The MRI cutaway is printed from permission from the 
National High Magnetic Field Lab website (http://www.magnet.fsu.edu/
education /tutorials/magnetacademy/mri/). Figures (A1–A2) are reprinted by 
permission from Pereira et al. (2007), copyright 2007 , National Academy of 
Sciences, U.S.A. Figures (B1–B3) are from Manganas et al. (2007) and are 
reprinted with permission from AAAS.
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our group recently identified a metabolite with main resonance at 
1.28 ppm, which was enriched in rodent NPCs and was used to indi-
rectly quantify adult human neurogenesis (Manganas et al., 2007).
This metabolite was initially discovered in rodent NPCs, grown 
as embryonically derived neurospheres, by high-field nuclear mag-
netic resonance (NMR; Manganas et al., 2007; Ma et al., 2011), 
although it had not been previously found in NPCs differentiated 
in culture from embryonic stem cells (ESCs; Jansen et al., 2006). Its 
association with neurogenesis in vivo was validated by microMR 
spectroscopy, which detected it in the rodent hippocampus, as well 
as in the cortex after NPC transplantation (Manganas et al., 2007). 
Furthermore, the amount of the metabolite detected by microMR 
spectroscopy correlated with the number of BrdU+ cells in the hip-
pocampus following an electroconvulsive shock-induced increase 
in endogenous neurogenesis. These studies further led to imaging 
of the human hippocampus, where this metabolite was expressed 
in very small amounts and was not detectable using conventional 
signal processing. Thus, to extract it from the human  1H-MRS, 
Manganas  et  al.  (2007)  utilized  singular  value  decomposition 
(SVD), a parametric method which models metabolite signals as 
decaying complex sinusoids in the time domain. The validity and 
reliability of SVD to quantify the 1.28 ppm signal encountered 
criticisms mostly due to potential overfitting of the data (Friedman, 
2008; Hoch et al., 2008; Jansen et al., 2008; Dong et al., 2009). 
However, most of these issues were addressed using simulated and 
semi-simulated data showing that the rate of false positives was 
less than 5% for the range of signal-to-noise ratios found in the 
initial studies (under −20 dB), and thus that the estimations of 
human NPCs based on the 1.28 ppm peak were reliable (Djuric 
et al., 2008). Overall, these issues have been considered a matter of 
optimization of the technique rather than a fundamental problem 
in the methodology (Romer et al., 2008; Dong et al., 2009), with 
the agreement that more research is necessary to unequivocally 
establish the 1.28 ppm spectral peak as a marker of neurogenesis 
with clinical value (Djuric et al., 2008; Romer et al., 2008; Dong 
et al., 2009).
The identity of the 1.28 ppm metabolite remains unknown. 
Although it most likely contains a lipid component (Manganas 
et al., 2007), its exact molecular nature has not yet been deter-
mined and its functional significance for neurogenesis awaits fur-
ther studies. Recent reports indicate that the 1.28 ppm and adjacent 
resonances may also be associated with apoptosis. A similar lipidic 
peak resonating at 1.30 ppm has been also reported in apoptotic rat 
gliomas in vivo (Liimatainen et al., 2008), and more recent stud-
ies have found that the 1.28 ppm peak in cultured NPC increased 
during conditions that favored quiescence and apoptosis (Ramm 
et al., 2009). Apoptosis is common in the hippocampal neurogenic 
niche, as vast amounts of newborn cells die (Sierra et al., 2010). 
Thus, whether the 1.28 ppm peak detected in living brains origi-
nates from living or apoptotic NPCs remains to be determined.
sItes of neurogenesIs In the adult human braIn
Nowadays, the consensus is that adult neurogenesis occurs in two 
main areas of the brain: the subgranular zone (SGZ) of the DG 
of the hippocampus, where new granule neurons are locally pro-
duced and have been associated with learning and memory, and 
longer acquisition time and has lower signal-to-noise ratio than 
bolus tracking (Lin et al., 1999). Nevertheless, the steady-state T1 
method is well-established for determining CBV (Zaharchuk, 2007) 
and has been recently used by the group of Scott Small to indirectly 
assess changes in adult human neurogenesis (Pereira et al., 2007).
The basis for the CBV studies of neurogenesis is the correlation 
between angiogenesis and neurogenesis. Increased cortical CBV 
correlates with angiogenesis in ischemia (Lin et al., 2002; Seevinck 
et al., 2010) and gliomas (Aronen et al., 2000; Cha et al., 2003). In 
turn, angiogenesis occurs in the hippocampal neurogenic niche 
(Palmer et al., 2000), and both angiogenesis and neurogenesis are 
elevated in the hippocampus following physical exercise (van Praag 
et al., 2005; Van der Borght et al., 2009). Thus, because of the cor-
relation of CBV–angiogenesis and angiogenesis–  neurogenesis, the 
CBV might provide an indirect measure of neurogenesis in the 
adult human hippocampus (Pereira et al., 2007). In fact, the CBV 
increased selectively in the human dentate gyrus (DG, where NPCs 
reside) after a 12-week exercise paradigm, and this increase cor-
related with cognitive performance, such as declarative memory 
but not delayed recognition (Pereira et al., 2007). As a valida-
tion experiment, the authors showed that in running mice, the 
CBV increased in the DG and not in other hippocampal areas, 
and this increase correlated with the number of 1- to 3-week-
old BrdU+ cells (Pereira et al., 2007). More recently, others have 
demonstrated increased number of micro-vessels occurring in 
parallel to increased proliferation (Ki67+ cells) and the number 
of newborn cells committed to the neuronal lineage (DCX+ cells) 
after 10 days of running (Van der Borght et al., 2009). However, it 
remains to be elucidated if the angiogenesis–neurogenesis coupling 
occurs in conditions other than exercise, which would render the 
CBV measurements for assessments of human neurogenesis more 
widely applicable.
Spectroscopic biomarker of NPCs
Here, the MRI modality used is proton magnetic resonance spec-
troscopy (1H-MRS), which exploits the magnetic properties of dif-
ferent protons to detect an array of small metabolites in the living 
tissue. Some protons of some metabolites are mobile in the mag-
netic field, and the relaxation of their spins can be detected by MR. 
This relaxation is observed as a sinusoid wave of decay in the time 
domain (free-induction decay, or FID), which is conventionally 
transformed into a function in the frequency domain (Fourier-fast 
transform, or FFT; Maletic-Savatic et al., 2008). The FFT is usually 
plotted as a graph of peaks representing the proton content of dif-
ferent metabolites. The x-axis represents the resonant frequency of 
each particular metabolite (in parts per million or ppm); and the 
y-axis represents the intensity of the signal, so that the integrated 
area under each peak is a readout of the amount of protons that 
contribute to that particular signal (Sibtain et al., 2007). Using 
this conventional signal analysis, a few relevant metabolites can be 
detected (Soares and Law, 2009): N-acetylaspartate (NAA), a marker 
of neurons whose major peak resonates at 2.02 ppm; Creatine, reso-
nating at 3.02 ppm, an energy metabolite considered to be stable 
and thus used as a house-keeping metabolite for normalization; and 
Myoinositol, a marker of astrocytes which resonates at 3.56 ppm. 
Other metabolites commonly analyzed include choline, alanine, 
lactate, glutamate, glutamine, glucose, and some macromolecular 
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NBs that reach the OB through the RMS (Kornack and Rakic, 2001; 
Pencea et al., 2001).
In humans, proliferating BrdU+ cells were found in the SVZ, but 
they did not co-localize with either GFAP or NeuN (Eriksson et al., 
1998). Similarly to human SGZ NPCs, the functional NPCs from the 
human SVZ were grown in vitro (Kukekov et al., 1999) and, more 
recently, isolated from the healthy and diseased elderly SVZ (Leonard 
et al., 2009). Further studies showed the presence of proliferating 
putative NPCs, labeled with nestin and PCNA (Bernier et al., 2000), 
as well as putative NBs, labeled with PSA-NCAM, in the human SVZ 
(Weickert et al., 2000). However, only recently was the human SVZ 
niche thoroughly described. First, a well-defined astrocytic ribbon 
formed by the B cells was observed in the SVZ, similarly to rodent 
SVZ, but no evidence of cells migrating in an organized RMS was 
found (Sanai et al., 2004). The human RMS remained elusive, until 
a report that it was organized around the lateral ventricular exten-
sion which reached the OB (Curtis et al., 2007b). This report was 
criticized by Alvarez-Buylla and colleagues, who claimed that it had 
not unquestionably proved the existence of an olfactory ventricle 
and the migrating, proliferating NBs in the RMS (Sanai et al., 2007). 
Further study then showed scarce cells that co-expressed markers of 
proliferation (PCNA) and NBs (PSA-NCAM), but no clear evidence 
of migration (Kam et al., 2009). In addition, it appears that the human 
RMS consists of four layers, similar to the SVZ (Kam et al., 2009), 
which prompted others to suggest that the human RMS may be a 
rostral extension of the proliferative zone, rather than the migratory 
pathway as found in rodents and non-human primates (Whitman 
and Greer, 2009). Nonetheless, there is no consensus in the literature 
on whether the SVZ/RMS are actively providing a source of newborn 
neurons to the human OB throughout adulthood.
Finally, the human OB hosts NPCs, which have been isolated 
from patients undergoing neurosurgery and grown in culture, where 
they differentiated into neurons, astrocytes, and oligodendrocytes 
(Pagano et al., 2000). In agreement, new neurons seem to be pro-
duced locally in the human OB, as shown by co-localization with 
Ki67 and NeuroD (Bedard and Parent, 2004). However, the signifi-
cance of local neurogenesis in the adult human OB is still debatable.
relevance of adult neurogenesIs to human dIsease
The majority of studies on human neurogenesis compare findings in 
healthy people to those in patients with a variety of neurological dis-
eases. A summary comparing the alteration in neurogenesis in rodent 
models of disease and human patients is shown in Table 2. These stud-
ies use immunohistochemistry to detect biomarkers of proliferation or 
specific cell-types, and thus are only able to report differences in pro-
liferation and putative NPCs and NBs (pNPCs, pNBs), but not actual 
neurogenesis (i.e., formation of new neurons). Thus, we label these 
detected cells “putative” because none of the studies demonstrated that 
proliferating cells differentiated into mature, functional neurons. To 
directly reach the conclusion that neurogenesis is occurring lineage 
tracing using BrdU or analogs is required.
epIlepsy
Epilepsy is a common human disease that affects more than 50 mil-
lion people worldwide (Kuruba et al., 2009). One of the most intrac-
table forms is temporal lobe epilepsy (TLE), characterized by altered 
mood   disorders; and the subventricular zone (SVZ), from where 
newborn cells migrate through the rostral migratory stream (RMS) 
and give rise to neurons in the OB, related to olfaction (Ma et al., 
2009). Additionally, there are recent reports of adult neurogenesis 
in the neocortex, as well as the striatum, amygdala, substantia nigra 
(SN), and a few other areas in the rodent brain, as reviewed by 
Gould (2007). In humans, multipotent progenitors have been iso-
lated from the temporal and frontal cortex, as well as the amygdala 
from patients undergoing brain resection due to epilepsy, trauma, 
or dysplasia (Arsenijevic et al., 2001). However, studies in healthy 
humans have suggested that neocortical neurogenesis is restricted 
to the perinatal period or, at least, that the contribution of adult-
born neurons to the total cortical population is extremely small 
and undetectable by 14C methods (Spalding et al., 2005; Bhardwaj 
et al., 2006).
neurogenesIs In the adult human hIppocampus
In rodents, the hippocampal neurogenic cascade starts with the qui-
escent neuroprogenitors (QNPs; type-1 cells; radial glia), which reside 
in the SGZ. QNPs proliferate, giving rise to a transient population, 
the amplifying neuroprogenitors (ANPs; type-2a cells) which in turn 
proliferate and differentiate into neuronal-committed NBs (type-2b 
and type-3 cells). Finally, at the end of a 4-week period, the surviving 
NBs become mature neurons integrated into the circuitry (reviewed 
by Kempermann et al., 2004; Encinas and Enikolopov, 2008).
In humans, adult hippocampal neurogenesis was demonstrated 
by analysis of postmortem tissue of cancer patients (Eriksson et al., 
1998), and changes in it under different conditions such as physical 
exercise and aging have been observed indirectly using CBV (Pereira 
et al., 2007) and 1H-MRS (Manganas et al., 2007) in healthy adults 
in vivo. The presence of functional NPCs in the adult human hip-
pocampus was further demonstrated by culture, expansion, and 
differentiation of human NPCs in vitro (Kukekov et al., 1999; Roy 
et al., 2000; Moe et al., 2005). A recent study has shown that the adult 
human SGZ contains DCX-expressing cells that co-localize both 
with markers of proliferation (MCM2, Ki67, PCNA) and mature 
neurons (NeuN, β-III-tubulin), supporting the existence of NBs 
throughout the human lifespan (Knoth et al., 2010).
Other studies, however, failed to detect NPCs or proliferating 
cells in the adult hippocampus of epileptic patients using immu-
nohistochemical methods, such as expression of nestin, vimentin, 
or Ki67 (Arnold and Trojanowski, 1996; Del Bigio, 1999; Blumcke 
et al., 2001; Seress et al., 2001; Fahrner et al., 2007). This conflicting 
literature can be explained by different sensitivities of the particu-
lar method used in each study. Overall, future work is needed to 
determine all components of the hippocampal neurogenic niche 
and the cellular types that comprise human neurogenic cascade.
neurogenesIs In the adult svZ
In rodents, the stem cells of the SVZ are specialized astrocytes called 
B cells. These cells proliferate and give rise to C cells, the transient 
amplifying population of the system (Doetsch et al., 1999). These C 
cells generate NBs or A cells, which form chains of proliferating cells 
that migrate ensheathed by astrocytes forming the RMS toward the 
OB, where they differentiate into granule cells and periglomerular 
interneurons (Lois et al., 1996). In non-human primates, the struc-
ture is notably similar, with astrocytic-like precursors in the SVZ 
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return to basal levels or even to be downregulated as compared 
to control animals (Kuruba et al., 2009).
Several studies have reported changes in adult neurogenesis 
in patients with TLE, who were all pharmacoresistant and had to 
undergo temporal lobectomy, providing the source for studies of 
neurogenesis. Utilizing Ki67 labeling the initial study showed no evi-
dence of proliferation in the adult epileptic SGZ, since the number 
of Ki67+ cells was not significantly larger compared to other DG 
regions (Del Bigio, 1999). In addition, the number of pNBs (PSA-
NCAM+ cells) was smaller in TLE patients than in age-matched 
controls (Mikkonen et al., 1998). Further comparison of adult TLE 
patients and controls showed similar levels of proliferation, meas-
ured by the number of Ki67+ and MCM2+ cells, as well as DCX 
protein expression and the number of DCX+ cells (Fahrner et al., 
2007). In contrast, pediatric (<19 months of age) TLE patients had 
electrical activity, aberrant synaptic reorganization and neurodegen-
eration in the hippocampus, as well as development of depression 
and impairments in learning and memory (Kuruba et al., 2009).
In rodents, there is abundant literature reporting that hippoc-
ampal neurogenesis increases in models of acute seizures, either 
by administration of glutamate receptors agonists such as kainic 
acid, or by electrical stimulation of the hippocampus or the piri-
form cortex. In these models an increment in the proliferation of 
the hippocampal NPCs results in a concomitant increase in the 
number of newborn neurons (reviewed by Parent, 2002; Curtis 
et al., 2007a; Kuruba et al., 2009). However, the newborn neurons 
are located ectopically (in the hilus and the molecular layer of the 
dentate gyrus) and display aberrant connectivity and morphology 
(Parent et al., 1997; Scharfman et al., 2000). The seizure-induced 
abnormal neurogenesis may have detrimental consequences and 
contribute to aberrant   synaptic   reorganization (Parent, 2002). In 
Table 2 | Adult neurogenesis during disease.
Disease  Area  rodent data  Human data
Epilepsy  Hippo.  Acute increase in proliferation  Increase in pNPCs and proliferation 
      in pediatric patients
    Acute increase in neurogenesis  Increase or no change in proliferation 
      in adult patients
    Aberrant and ectopic new neurons  Decrease, no changed or increase in
    Chronic depletion  pNBs in adult patients
Huntington’s disease  SVZ  Increased or unchanged SVZ proliferation  Increase in proliferation; thicker SVZ
    migration of new neurons into the striatum  increase in pNPCs and pNBs
Alzheimer’s disease  SVZ  Decrease in proliferation  Decrease in proliferation
    Decrease in differentiation  Increase in pNPCs
  Hippo.  Increase, no change or decrease in proliferation  No change in proliferation
    Increase in neurogenesis  Increase in pNBs
    Decrease in differentiation and survival of   
    newborn neurons
Parkinson’s disease  SVZ  Decrease in proliferation  Decrease in proliferation
    Transient decrease in OB neurogenesis  Decrease in putative OB progenitors
    Increase in OB neurogenesis and total neurons  Increase in OB neurogenesis and 
      DA neurons
  Hippo.  Decrease in proliferation  Decrease in pNPCs
  S. nigra  No proliferation or NPCs  No proliferation or pNPCs
    Induction of neurogenesis 
Stroke  SVZ  Increase in proliferation  NR
    Increase in neurogenesis 
  Hippo.  Increase in proliferation  NR
    Increase in neurogenesis 
  Striatum  Induction of neurogenesis from SVZ progenitors  NR
  Cortex  Induction of neurogenesis from SVZ progenitors  Increase in proliferation
      Increase in pNBs
Depression  Hippo.  Antidepressants increase proliferation  Increase or no changes in proliferation  
    and neurogenesis
      Increase in pNPCs in patients treated 
      with antidepressants
This table summarizes the major changes in neurogenesis in human neurological and psychiatric disorders. For details and references, see main text.
Hippo., hippocampus; S. nigra, substantia nigra; NR, non-reported.
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staining in the SVZ lining of the striatum compared to age-matched 
controls, suggesting an increase in SVZ proliferation. Additionally, 
the expression levels of PCNA correlated with the number of CAG 
repeats in these patients. The proliferating cells expressed markers 
of glia (GFAP) and neurons (β-III-Tubulin), suggesting the pres-
ence of putative B and A cells, respectively (Curtis et al., 2003). 
Further, the SVZ was thicker due to an increase in the number of B 
cells, identified by cellular morphology, and the number of dividing 
cells, labeled with PCNA, in HD patients compared to age-matched 
controls (Curtis et al., 2005a,b). Unexpectedly, some of the prolif-
erating PCNA+ cells expressed markers of mature neurons such 
as βIII-Tubulin and this was interpreted as increased neurogenesis 
in HD patients (Curtis et al., 2005a). However, it takes days, if not 
weeks, for newborn cells to express markers of mature neurons. 
Therefore, an aberrant expression of PCNA in mature neurons 
or an aberrant expression of βIII-Tubulin in dividing cells in the 
SVZ of HD patients cannot be ruled out. Finally, migration of the 
newborn cells from the SVZ into the damaged human striatum and 
their neuronal differentiation has not been described yet and, thus, 
it remains unknown if the endogenous SVZ cells can be harnessed 
for repair in HD patients.
alZheImer’s dIsease
Alzheimer’s  disease  (AD)  is  characterized  by  accumulation  of 
β-amyloid and neurofibrillary tangles containing hyperphospho-
rylated tau protein throughout the cortex and the hippocampus, 
resulting  in  progressive  dementia  (Curtis  et  al.,  2007a).  Some 
pathological features of AD can be modeled in transgenic mice 
overexpressing amyloid precursor protein and presenilin 1 (APP/
PS1). In these mice, memory impairment and increased hippoc-
ampal proliferation and neurogenesis were observed at 9, but not 
3 months of age (Yu et al., 2009). However, earlier works showed 
that 6-month-old APP/PSE1 mice have unaltered proliferation and 
short-term survival (1–13 days), whereas they have a significant 
reduction of long-term survival (30–42 days) and differentiation 
(Verret et al., 2007). In addition, other transgenic mouse models of 
AD have shown otherwise. For instance, in triple transgenic mice 
(APP/PSE1/Tau) there is a gradual decrease in SGZ proliferation 
starting at 6 months of age (Rodriguez et al., 2008). On the other 
hand, 3-month-old mice expressing mutated APP have increased 
proliferation (Jin et al., 2004a) although this increase was reverted 
to control levels in older animals (Lopez-Toledano and Shelanski, 
2007). Finally, in 6-week-old transgenic mouse expressing human 
APP showed decreased proliferation in control housing conditions 
as well as a decreased 4-week survival in enriched environment 
conditions (Naumann et al., 2010). In postmortem hippocampal 
samples from patients with advanced AD, an increased expression 
of NB proteins (DCX, PSA-NCAM, and NeuroD) compared to 
age-matched controls was reported, suggesting increased neuro-
genesis perhaps as a compensatory mechanism to cope with the 
AD-related cognitive impairment (Jin et al., 2004b). However, 
a more recent study of presenile AD patients failed to demon-
strate increased proliferation in the DG, whereas it showed an 
increased proliferation (Ki67+ cells) associated with gliogenesis 
and angiogenesis in other hippocampal regions. Further, the same 
study attributed changes in DCX immunolabeling to postmortem 
increased number of proliferating pNPCs, labeled with nestin and 
Ki67 (Blumcke et al., 2001). More recent studies, however, contra-
dict the previous literature. One study described a not quantified 
increase in proliferating cells (PCNA+ cells), and pNPCs (vimentin, 
musashi+ cells) in the SGZ and SVZ of adult TLE patients compared 
to controls (Crespel et al., 2005), while another reported augmented 
DCX protein and gene expression and number of pNBs (DCX+ 
cells) in TLE patients in the hippocampus and other temporal cor-
tical regions (Liu et al., 2008). In these patients the DCX+ cells 
expressed markers of the neuronal lineage, such as PSA-NCAM or 
NeuN, but the authors did not provide the rationale for their find-
ings contradicting previous literature and only noted that the effect 
of TLE on human neurogenesis was not as “dramatic” as in animal 
models of epilepsy (Liu et al., 2008). Finally, although many ex vivo 
studies showed the presence of functional NPCs in the epileptic hip-
pocampus (Kukekov et al., 1999; Roy et al., 2000; Moe et al., 2005), it 
has been recently shown that their proliferative and multipotential 
properties in vitro depend on disease duration and were almost 
absent in epileptic patients with mesial temporal sclerosis, a late 
consequence of TLE (Paradisi et al., 2010). In conclusion, in infants, 
epilepsy is associated with increased proliferation in the hippocam-
pus, but whether this proliferation leads to an increase of newborn 
neurons remains unknown. In adults, reports are controversial and 
most likely reflect a wide range of disease duration, which apparently 
affects NPCs (Paradisi et al., 2010). Whether changes in neurogen-
esis also relate to the changes in mood and cognitive performance 
observed in TLE patients remains to be determined.
Epilepsy  also  alters  SVZ  neurogenesis.  In  rats,  pilocarpin-
induced status epilepticus produced an increased proliferation of 
SVZ NPCs as well as an expansion of the RMS, which contained 
more proliferating cells and NBs (Parent et al., 2002). In addi-
tion, some cells in the RMS were found to migrate ectopically into 
the surrounding cortical parenchyma, although the majority of 
these ectopic cells did not survive (Parent et al., 2002). In human, 
increased proliferation, ectopic parenchymal migration, and neuro-
nal differentiation were also found using organotypic slice prepara-
tions from tissue resected from patients with a variety of intractable 
cortical seizures (Gonzalez-Martinez et al., 2007). The functional 
significance of increased neurogenesis and ectopic migration of 
SVZ precursors induced by SE in rodents and humans remains to 
be established.
huntIngton’s dIsease
Huntington’s disease (HD) is caused by expanded CAG repeats 
in the huntingtin gene, which leads to protein accumulation and 
neurodegeneration in the striatum, a brain area that lies below the 
SVZ. In transgenic mice models of HD, in which little striatal neu-
rodegeneration occurs, neurogenesis in the SVZ remains unaltered; 
whereas in rat models of striatal degeneration an increased SVZ pro-
liferation is observed (reviewed by Curtis et al., 2007a). Interestingly, 
some of the newly generated cells are able to migrate into the dam-
aged striatum, where they express neuronal markers (Tattersfield 
et al., 2004), although it is unknown whether they are functionally 
mature neurons. These results suggested an endogenous regenera-
tion potential in HD because the new born neurons would take long 
time to develop huntingtin inclusions and in the meanwhile could 
contribute to maintaining the striatal circuitry (Curtis et al., 2007a).
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in up to 95% of PD patients prior to the onset of other clinical 
symptoms (Haehner et al., 2009). Dopaminergic innervation may 
also regulate neurogenesis in the hippocampus. In rodents, lesions 
of the nigrostriatal pathway decrease hippocampal proliferation 
(Hoglinger et al., 2004; Suzuki et al., 2010), and in the hippocampus 
of PD patients, less pNPCs (nestin+ cells) are observed compared to 
age-matched controls (Hoglinger et al., 2004). While initial reports 
suggested the neurogenesis was induced in the SN in rodent models 
of PD (Zhao et al., 2003), later studies, however, showed no evi-
dences of proliferation or NPCs in the SN either in rodent models 
of PD (Frielingsdorf et al., 2004; Yoshimi et al., 2005) nor in PD 
patients (Yoshimi et al., 2005).
stroke/IschemIa
A stroke, or cerebrovascular accident, results from occlusion of 
cerebral arteries leading to decreased local blood flow (ischemia) 
or from a hemorrhage. In the stroked tissue, two areas of injury 
can be discriminated: the core infarcted area, where neurons die 
of necrosis and very little, if any, regeneration is possible; and the 
penumbra area, which surrounds the infarcted area, is perfused by 
collateral arteries, and is not irreversibly damaged. Given that the 
ischemic stroke is the third most frequent cause of mortality in 
industrialized countries, major scientific efforts have been directed 
toward discoveries of therapies to facilitate recovery from the insult.
In rodent and non-human primate models of stroke, such as 
occlusion of the medial cerebral artery occlusion (MCAO), adult 
neurogenesis is up-regulated both in the SVZ–RMS–OB and the 
hippocampus (Jin et al., 2001; Zhang et al., 2001; Koketsu et al., 
2006; Lledo et al., 2006). In addition, stroke also induces ectopic 
neurogenesis in penumbra areas, such as the striatum, due to 
atypical migration of SVZ newborn cells (Arvidsson et al., 2002). 
Cortical neurogenesis in the penumbra area in rodent models of 
stroke has been found by some (Gu et al., 2000; Jin et al., 2003) but 
not by others (Arvidsson et al., 2002). Interestingly, the newborn 
cells differentiated into striatal neurons and acquired the same 
phenotype of the neurons which had died as a consequence of 
the stroke, suggesting that neuronal replacement can occur in the 
stroked striatum (Arvidsson et al., 2002). Although the vast major-
ity of the striatal newborn cells died, possibly due to an unfavorable 
environment (Arvidsson et al., 2002), stroke-induced striatal neu-
rogenesis seems to have functional consequences in rodents, since 
it has been shown that the transgenic ablation of the NB protein 
DCX prevented stroke-induced neurogenesis and worsened the 
sensorimotor and behavioral deficits after MCAO (Jin et al., 2010).
This research indicated that harnessing aberrant striatal neuro-
genesis in stroke may be useful to reduce the neurological deficits 
in patients (reviewed in Zhang and Chopp, 2009). The patients 
who suffered the ischemic, middle cerebral artery stroke showed 
increased proliferation of putative B cells (Ki67, GFAP+ cells) and 
putative C cells (PSA-NCAM+ cells), in the ipsilateral SVZ com-
pared to the contralateral side of the stroke (Marti-Fabregas et al., 
2010). In addition, there were traces of ectopic neurogenesis not in 
the striatum, but in the cortex. A significant increase in proliferat-
ing Ki67+ cells and pNBs (PSA-NCAM+ cells) was found in the 
cortical penumbra region of ischemic stroke patients compared to 
age-matched controls (Jin et al., 2006; Macas et al., 2006) as well 
breakdown (Boekhoorn et al., 2006). Thus, it is clear that more 
comprehensive studies are needed to clarify the changes in SGZ 
neurogenesis in AD. Furthermore, the relation between potentially 
altered neurogenesis and the cognitive impairments observed in 
AD remains to be elucidated (Lazarov et al., 2010).
Subventricular  zone  neurogenesis  is  also  altered  in  mouse 
AD-models. For instance, transgenic APP or PSE1 mice as well as 
wild-type mice infused in the lateral ventricles with βA peptide had 
reduced SVZ proliferation compared to control mice (Haughey et al., 
2002; Rodriguez et al., 2009; Veeraraghavalu et al., 2010). Decreased 
proliferation and neuronal differentiation were also observed in 
cultured NPCs isolated from PSE1 mutant SVZ (Veeraraghavalu 
et al., 2010) and from APP/PS1 mutant SVZ (Demars et al., 2010). 
In human AD patients, decreased proliferation (Ki67+ cells) accom-
panied by a puzzling increase in nestin expression was observed in 
postmortem sections (Ziabreva et al., 2006). In agreement, cultured 
embryonic human NPC had decreased proliferation and increased 
apoptosis when treated with Aβ peptide compared to control NPCs 
treated with vehicle (Haughey et al., 2002). Thus, there are consist-
ently lower levels in SVZ neurogenesis in AD patients as well as in 
and rodent AD models, prompting the suggestion that impaired 
SVZ neurogenesis may have functional consequences in AD (Curtis 
et al., 2007a). For instance, olfactory deficits significantly predict 
development of AD in patients with mild cognitive impairment 
(Devanand et al., 2000), although whether these olfactory deficits 
are related to decreased SVZ neurogenesis remains unknown.
parkInson’s dIsease
The major hallmark of the Parkinson’s disease (PD) is the death 
of dopaminergic neurons in the SN, with consequent impairment 
of movement control, mood, and motivation (Hoglinger et al., 
2004). In animal models of PD, a reduced proliferation in the 
SVZ overlaying the striatum is observed. C and A cells in the SVZ 
receive dopaminergic fibers from the SN (Hoglinger et al., 2004). In 
rodents, this dopaminergic innervation controls the proliferation of 
these two cell types, because the injection of a toxic dopamine ana-
log (6-hydroxydopamine) in the nigrostriatal pathway dennervates 
both the striatum and the SVZ and results in decreased SVZ pro-
liferation (Hoglinger et al., 2004), resulting in a transient decrease 
of newborn neurons in the OB granule cell layer (Hoglinger et al., 
2004; Winner et al., 2006). In the lesioned mice, administration 
of a dopaminergic precursor (levodopa) partially recovered SVZ 
proliferation close to control levels (Hoglinger et al., 2004). Similar 
results were obtained in PD patients. The number of SVZ prolif-
erating cells, labeled with PCNA, as well as OB pNPCs (nestin+ 
cells) was reduced compared to age-matched controls (Hoglinger 
et al., 2004), although no changes in the number of cells in the OB 
granule cell layer have been reported.
Interestingly, in the OB glomerule cell layer there is an increase 
in the number of newborn as well as total dopaminergic cells, 
expressing the synthesizing enzyme tyrosine hydroxylase, both in 
rodents whose nigrostriatal pathway was lesioned with 6-hydroxy-
dopamine (Winner et al., 2006) and in PD patients (Huisman et al., 
2004). This increase in dopaminergic cells remains unexplained 
and it is unexpected in the light of the decreased SVZ proliferation. 
Nonetheless, because dopamine inhibits olfactory transmission, it 
has been suggested that the increase in OB dopaminergic neurons 
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nection of stress, anxiety, and MDD is not trivial, because the most 
commonly utilized rodent models of depression, such as learned 
helplessness, chronic mild stress, and chronic psychosocial stress 
induce depressive behaviors by increasing stress levels (Vollmayr 
et al., 2007; Pryce and Seifritz, 2011). Stress, through the actions of 
glucocorticoids, reduces adult hippocampal neurogenesis (Mirescu 
and Gould, 2006), produces dendritic atrophy (McEwen, 2001), 
and leads to decreased hippocampal volume (Tata and Anderson, 
2010). From the rodent literature, it is therefore difficult to extract 
a clear picture of whether the alterations in adult hippocampal 
neurogenesis are due to stress, anxiety, depression, or a combina-
tion of these factors.
In MDD patients, recent studies have shown alterations in adult 
hippocampal neurogenesis (Reif et al., 2006; Boldrini et al., 2009). 
An initial study on postmortem samples of a cohort of 15 MDD 
patients showed no alterations in proliferation (Ki67+ cells) com-
pared to age-matched controls (Reif et al., 2006). In contrast, a more 
recent study of a cohort of 19 MDD patients treated with TCAs 
such as nortriptyline, showed a significant increase in proliferation 
(Ki67+ cells) compared to the untreated MDD patients. In addition, 
a significant increase in the number of pNPCs (nestin+ cells) was 
found in patients treated with TCAs or SSRIs such as fluoxetine, 
compared to the untreated MDD patients (Boldrini et al., 2009). 
Interestingly, and similar to the observation that decreased neuro-
genesis is not required to induce depression-like behavior in rodents 
(Vollmayr et al., 2007), there were no significant differences in the 
number of proliferative cells or pNPCs in MDD patients compared 
to age-matched controls (Boldrini et al., 2009). Several limitations 
where identified, such as the small sample size, the possibility that 
treated MDD patients had more severe symptoms than untreated 
patients (hence, the prescription of pharmacological treatment), 
and the high incidence of suicide in the untreated patients (Boldrini 
et al., 2009). Taken together, these data suggest that decreased 
neurogenesis is not causative for depressive symptoms; however, 
treatment with antidepressants does improve the symptoms while 
increasing neurogenesis in the adult hippocampus. Further research 
needs to test the correlations between neurogenesis, MDD, stress, 
and antidepressant drugs. In particular, methods to assess human 
neurogenesis in vivo are of particular importance for longitudinal 
studies in MDD patients, to quantify neurogenesis before and after 
the antidepressant treatment, and in correlation with the onset and/
or improvement of depressive symptoms.
mIscellanea
Finally, there is also sporadic evidence that adult neurogenesis may 
be altered in other brain diseases. For instance, in traumatic brain 
injury, increased hippocampal proliferation has been reported in 
humans (Gerber et al., 2009) and mice (Yu et al., 2008). In patients 
with hypoxic-ischemic encephalopathy, which results in neuronal 
loss in the cortex and the hippocampus, there is a non-significant 
increase in PCNA labeled cells (Mattiesen et al., 2009). During bacte-
rial meningitis an increase in hippocampal proliferation as well as 
the number of pNBs was observed (Gerber et al., 2009), although in 
mice inflammation results in decreased proliferation and neurogen-
esis (Monje et al., 2003). In patients with subarachnoid   hemorrhage, 
increased mRNA and protein levels of vimentin, musashi, and   nestin 
as in perihematomal regions in patients with intracerebral hemor-
rhage (Shen et al., 2008). The relevance of this increase in cortical 
neurogenesis in stroke patients remains to be investigated, but the 
phenomena certainly raise the hope that neurogenesis might be 
harnessed as a possible treatment for stroke patients.
mood dIsorders
Depression, or major depressive disorder (MDD), is characterized 
by anhedonia and the absence of positive affect (Craske et al., 2009). 
MDD is thought to be caused by an imbalance in the levels of 
monoamines, such as serotonin and noradrenalin, as formulated 
in the “monoamine hypothesis of depression” (Duman et al., 2000; 
Wong and Licinio, 2001). This hypothesis is strongly supported 
by the ability of antidepressant drugs, such as selective serotonin 
reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs), 
to improve the symptomatology by increasing synaptic levels of 
monoamines (Wong and Licinio, 2001). However, while antidepres-
sant drugs modify monoamine levels within hours, it takes weeks 
of daily treatments to observe the behavioral effects, indicating that 
long-term changes underlie the effects of antidepressant therapies 
(Wong and Licinio, 2001). Structural changes in the cortex and hip-
pocampus, such as alterations in neuronal morphology, synaptic 
plasticity, and cell survival, may also be part of the disease (Duman 
et al., 2000). For instance, MDD patients may have hippocampal 
atrophy (Sheline et al., 1996), which correlates with poor cogni-
tive performance in these patients (Frodl et al., 2006). In addition, 
MDD patients have decreased pyramidal neuronal soma size and 
higher density of glial, pyramidal, and granule cells in the hippoc-
ampus compared to age-matched controls (Stockmeier et al., 2004). 
Together, these results suggest a significant reduction in the neuropil 
(glial and neuronal processes) in MDD patients (Stockmeier et al., 
2004). While the absolute numbers of glia and neurons in the hip-
pocampus of MDD patients are unknown (Stockmeier et al., 2004), 
small increases in hippocampal apoptosis in MDD patients have 
been reported (Lucassen et al., 2001).
The hippocampal pathology in MDD has led to the “neuro-
genesis hypothesis of depression.” Postulated by Drew and Hen 
(2007), the hypothesis states that altered levels of adult hippoc-
ampal neurogenesis may underlie the pathology of depression as 
well as the behavioral effects of antidepressants. This hypothesis is 
based on several lines of evidence showing that in rodents, chronic 
antidepressant  treatments  increase  hippocampal  neurogenesis 
(Malberg et al., 2000) and that, conversely, hippocampal neuro-
genesis is necessary for the behavioral effects of antidepressant 
drugs (Santarelli et al., 2003). The main caveat of this hypothesis 
is that neurogenesis seems not to be sufficient to cause depression, 
because decreased neurogenesis does not always induce depressive 
behaviors, and vice versa, depressive behaviors can be induced in 
experimental paradigms that do not affect neurogenesis (Vollmayr 
et al., 2007). To further complicate the interpretation of the data, 
the depression-induced morphological alterations, including those 
in neurogenesis, have generally been blamed on depression-related 
stress (Duman et al., 2000).
Stress, or more properly, the failure to adapt to stressful situa-
tions, is a shared symptom of depression and other mood disorders, 
such as anxiety and fear disorders (Craske et al., 2009), although 
is still under debate whether it is a concurrent epiphenomenon or 
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